Conferences Ergomed is attending in 2026–2027

LinkedIn ergomedcro.com

Ergomed is listed at 3 conferences on Tnuki's calendar in 2026–2027: ESMO 2026 (exhibiting), SCOPE 2027 (Corporate Support Sponsor) and ASCO 2027 (exhibiting). Ergomed provides contract research and pharmacovigilance services for pharmaceutical and biotechnology companies. As of Oct 17, 2026.

Show
ConferenceDetailsInvolvementTnuki guide
ESMO Congress 2026Europe’s medical oncologists & cancer researchersOfficial site
Madrid, Spain ~37k attendees ExhibitorAs published by European Society for Medical Oncology
Booth 1097
Attendee mix: Mostly clinical; oncologists, KOLs, cancer researchers, medical affairs and oncology biopharma teams
Open the guide Search and filter attendees
SCOPE Summit 2027Clinical operations & trial technology leadersOfficial site
Orlando, FL ~5k attendees ◇Corporate Support SponsorAs published by SCOPE Summit
Listed in the SCOPE 2027 guide; no booth or program details yet
Attendee mix: Almost entirely industry; clinical operations executives at pharma, biotech and CROs
Open the guide Search and filter attendees
ASCO Annual Meeting 2027World’s largest clinical oncology meetingOfficial site
Chicago, IL ~44k attendees ExhibitorAs published by American Society of Clinical Oncology
Booth 33130
Attendee mix: Mostly clinical; oncologists, KOLs, clinical researchers, medical affairs and oncology biopharma teams
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Ergomed’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Ergomed

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →